<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>neurontin gabapentin Archives - Abraham Dental Art</title>
	<atom:link href="https://abrahamdentalart.com/tag/neurontin-gabapentin/feed/" rel="self" type="application/rss+xml" />
	<link>https://abrahamdentalart.com/tag/neurontin-gabapentin/</link>
	<description>Wesley Chapel, FL</description>
	<lastBuildDate>Sat, 15 Aug 2026 21:41:35 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.4</generator>

<image>
	<url>https://abrahamdentalart.com/wp-content/uploads/2025/10/cropped-favicon-32x32-1-1-32x32.png</url>
	<title>neurontin gabapentin Archives - Abraham Dental Art</title>
	<link>https://abrahamdentalart.com/tag/neurontin-gabapentin/</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">254017125</site>	<item>
		<title>Advanced Dental Analgesia Protocols for 2026</title>
		<link>https://abrahamdentalart.com/advanced-dental-analgesia-protocols-for-2026/</link>
		
		<dc:creator><![CDATA[DentalArt]]></dc:creator>
		<pubDate>Fri, 07 Aug 2026 18:01:42 +0000</pubDate>
				<category><![CDATA[Dental Laboratory]]></category>
		<category><![CDATA[dental analgesia]]></category>
		<category><![CDATA[dental pharmacology]]></category>
		<category><![CDATA[mandibular pain]]></category>
		<category><![CDATA[neurontin gabapentin]]></category>
		<category><![CDATA[neuropathic dental pain]]></category>
		<guid isPermaLink="false">https://abrahamdentalart.com/?p=1801</guid>

					<description><![CDATA[Pathophysiology of Complex Orofacial Pain and Neuropathic Dental Disorders in 2026 Management of acute dental pain has historically relied on non-steroidal anti-inflammatory drugs (NSAIDs), acetaminophen, and short-course opioid therapy. However, clinical dentistry in 2026 faces an evolving demographic of patients presenting with complex, refractory orofacial pain syndromes that fail standard peripheral analgesic regimens. Conditions such [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">1801</post-id>	</item>
	</channel>
</rss>
